Skip to main content
OpenTrials
Completed

NCT Number: NCT03363113

Outcome of Botulinum Toxin Treatment for Oromandibular Dystonia

Symptoms of oromandibular dystonia can be alleviated by injections of botulinum toxin. The scope of this study is to describe the efficacy of this procedure, by a retrospective systematic review of patients medical charts

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient suffering from oromandibular dystonia
  • Medical follow up in the Fondation Ophtalmologique Rothschild (Paris)
  • Treatment by at least one session of botulinum toxin injection

Exclusion criteria

  • Patient cannot assess symptoms improvement using a Likert scale

Treatment and study plan

Botulinum Toxins

Drug

Injection of botulinum toxin in the muscles affected by oromandibular dystonia

Primary outcomes

  1. Clinical improvement score

    Time frame: Two months

    Likert scale for the assessment of the clinical improvement after treatment

Sponsors and collaborators

Lead sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Network

Registry information

Acronym: rétroBODOM

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Dec 6, 2017
Registry last updated
Dec 6, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.